Protective effects of melatonin on ischemia-reperfusion injury of skeletal muscle;Melatoninin iskelet kası iskemi-reperfüzyon yaralanması üzerine koruyucu etkisi

Eklem Hastaliklari ve Cerrahisi

Volumn 21, Issue 3, 2010, Pages 166-171

  Erdem, Mehmet ^a   Bostan, Bora ^a   Güneş, Taner ^a   Özkan, Fatih ^b   Şen, Cengiz ^a   Özyurt, Hüseyin ^c   Köseoǧlu, Reşit Doǧan ^d   Erdoǧan, Hasan ^e  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b Anesteziyoloji ve Reanimasyon Anabilim Dali   (Turkey)

^c Biyokimya Anabilim Dali   (Turkey)

^d Anatomi Anabilim Dali   (Turkey)

^e Fizyoloji Anabilim Dali   (Turkey)

Author keywords

Ischemia reperfusion injury; Melatonin; Reactive oxygen species; Skeletal muscle

Indexed keywords

MELATONIN; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; DRUG EFFECT; INJURY; LIMB; MALE; PATHOLOGY; RAT; REPERFUSION INJURY; SKELETAL MUSCLE; VASCULARIZATION; WISTAR RAT;

ANIMALS; EXTREMITIES; MALE; MELATONIN; MUSCLE, SKELETAL; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 78649268801     PISSN: 13058282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cheeseman KH. Mechanisms and effects of lipid per-oxidation. Mol Aspects Med 1993;14:191-7.
2. Clanton TL, Zuo L, Klawitter P. Oxidants and skeletal muscle function: physiologic and pathophysiologic implications. Proc Soc Exp Biol Med 1999;222:253-62.
3. Matés JM. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000;153:83-104.
4. Frei B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med 1994;97:5S-13S.
5. Rodriguez C, Mayo JC, Sainz RM, Antolín I, Herrera F, Martín V, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004;36:1-9.
6. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003;34:1-10.
7. Reiter RJ. Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab 2003;17:273-85.
8. Erkanli K, Kayalar N, Erkanli G, Ercan F, Sener G, Kirali K. Melatonin protects against ischemia/reperfusion injury in skeletal muscle. J Pineal Res 2005;39:238-42.
9. Kondoh T, Uneyama H, Nishino H, Torii K. Melatonin reduces cerebral edema formation caused by transient forebrain ischemia in rats. Life Sci 2002;72:583-90.
10. Lagneux C, Joyeux M, Demenge P, Ribuot C, Godin-Ribuot D. Protective effects of melatonin against ischemia-reperfusion injury in the isolated rat heart. Life Sci 2000;66:503-9.
11. Okatani Y, Wakatsuki A, Reiter RJ, Enzan H, Miyahara Y. Protective effect of melatonin against mitochondrial injury induced by ischemia and reperfusion of rat liver. Eur J Pharmacol 2003;469:145-52.
12. Sener G, Sehirli AO, Keyer-Uysal M, Arbak S, Ersoy Y, Yeǧen BC. The protective effect of melatonin on renal ischemia-reperfusion injury in the rat. J Pineal Res 2002;32:120-6.
13. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
14. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988; 34:497-500.
15. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte gluta-thione peroxidase. J Lab Clin Med 1967;70:158-69.
16. Aebi H. Catalase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. 2nd ed. New York: Academic Press; 1974. p. 673-7.
17. Esterbaur H, Cheeseman KH. Determination of alde-hydic lipid peroxidation products: malonaldehyde and 4-hyroxynonenal. In: Packer L, Glazer AN editors. Methods in enzymology. Vol. 186. New York: Academic Press; 1990. p. 407-21
18. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990;36:1440-3.
19. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, et al. Determination of carbonyl content in oxidatively modified proteins. In: Packer L, Glazer AN, editors. Methods in enzimology. Vol. 186. New York: Academic Press; 1990. p. 464-78.
20. Klenerman L, Biswas M, Hulands GH, Rhodes AM. Systemic and local effects of the application of a tourniquet. J Bone Joint Surg [Br] 1980;62:385-8.
21. Patterson S, Klenerman L. The effect of pneumatic tourniquets on the ultrastructure of skeletal muscle. J Bone Joint Surg [Br] 1979;61-B:178-83.
22. Sanders WE. Principles of microvascular surgery. In: Green DP, editor. Operative hand surgery. Vol. 1. 3rd ed. New York: Churchill Livingstone; 1993. p. 1039-83.
23. Wang WZ, Fang XH, Stephenson LL, Baynosa RC, Khiabani KT, Zamboni WA. Microcirculatory effects of melatonin in rat skeletal muscle after prolonged ischemia. J Pineal Res 2005;39:57-65.
24. Toledo-Pereyra LH, Lopez-Neblina F, Toledo AH. Reactive oxygen species and molecular biology of ischemia/reperfusion. Ann Transplant 2004;9:81-3.
25. Ozyurt H, Ozyurt B, Koca K, Ozgocmen S. Caffeic acid phenethyl ester (CAPE) protects rat skeletal muscle against ischemia-reperfusion-induced oxidative stress. Vascul Pharmacol 2007;47:108-12.
26. Petrasek PF, Homer-Vanniasinkam S, Walker PM. Determinants of ischemic injury to skeletal muscle. J Vasc Surg 1994;19:623-31.
27. Reiter RJ. Antioxidant actions of melatonin. Adv Pharmacol 1997;38:103-17.
28. Pattwell D, McArdle A, Griffiths RD, Jackson MJ. Measurement of free radical production by in vivo microdialysis during ischemia/reperfusion injury to skeletal muscle. Free Radic Biol Med 2001;30:979-85.